c
2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
50
4e
1d
2 29
1d
25
Katheryn Alexandra Quilico Cousins-Gershenson, PhD
88
4e
Research Assistant Professor of Neurology
7
60
Department: Neurology
4
1
23
1f
Graduate Group Affiliations
8
b
-
64
- Neuroscience e
1d
46
Contact information
54
4
3
3
3
2
4
b
1f
54
Richards Medical Building, Suite 600B
35 3700 Hamilton Walk
Philadelphia, PA 19104
26
35 3700 Hamilton Walk
Philadelphia, PA 19104
35
af
12
13
Education:
21 7 BA 21 ( Biological Sciences) c
2e University of Chicago, 2007.
21 8 PhD 19 (Neuroscience) c
2c Brandeis University, 2015.
c
3
3
3
3
92
Permanent link21 7 BA 21 ( Biological Sciences) c
2e University of Chicago, 2007.
21 8 PhD 19 (Neuroscience) c
2c Brandeis University, 2015.
c
2 29
21
1e
1d
24
5e
e 29
27
Description of Research Expertise
32 Biofluid markers of neuropathologye 29
23
176 Cousins, Boyle, Morse, Verma, Brown, O’Brien, Serper, Dehghani, Penn Medicine BioBank, McMillan, Lee, Shaw, & Wolk: Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s disease. Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
187 Simrén, Rönnholm, Weiner, Pola, Benedet, Shaw, Wolk, Weintraub, Lee, McMillan, Blennow, Irwin, Zetterberg*, Gobom*, & Cousins*: Cerebrospinal fluid proteomic profiling in frontotemporal lobar degeneration, Alzheimer’s disease and Lewy body disease. Invited Talk: Biomarker Signatures in Preclinical AD and Neurodegenerative Diseases 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
1d4 Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.: Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch. JAMA Neurol 83: 126-136, Feb 2026.
168 Cousins KAQ, Boyle R, Morse C, Verma A, Brown CA, O'Brien KS, Serper M, Dehghani N; Penn Medicine BioBank; McMillan CT, Lee EB, Shaw LM, Wolk DA.: Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease. Ann Neurol Dec 2025.
84 Kwiecinski, Dratch, Andrews, Dengel, Kamel, Legaspi, McMillan, Massimo, Cousins, & Irwin d4 : Evaluating the Impact of Predictive Genetic Counseling in Frontotemporal Dementia: A Pilot Analysis. National Society of Genetic Counselors (NSGC) 44th Annual Conference Nov 2025.
7b Ohm, Capp, Sabitini, Cousins, Phillips, Rascovsky, Wolk, Lee, McMillan, & Irwin 2 a1 : Selectively vulnerable myeloarchitecture in behavioral variant frontotemporal dementia. Society for Neuroscience (SfN) Nov 2025.
16f Luna, Cousins, Emrani, Luk, Lee, Lee, Weintraub, Xie, Chen-Plotkin, Bennett, & Irwin: Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner. International Congress of Parkinson’s Disease and Movement Disorders Oct 2025.
19b Brown CA, Cousins KAQ, Korecka M, McGrew E, Chen-Plotkin A, Detre JA, McMillan CT, Lee EB, Das SR, Mechanic-Hamilton D, Yushkevich PA, Nasrallah IM, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative; Wolk DA.: Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease using PET and Plasma Biomarkers. medRxiv Sep 2025.
1b1 Boyle R, Dehghani N, Emrani S, Wadhwani AR, Matyi M, Cousins KAQ, Rhodes E, Nelson B, Stites SD, Xie SX, Dratch L, Van Deerlin VM, Snyder A, Irwin DJ, McMillan CT, Massimo L.: Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degeneration. Alzheimers Dement Behav Socioecon Aging Sept 2025.
2c
7
1d
1f
Selected Publications
203 Honey, Thijssen, Hok-A-Hin, Cousins, Weijden, Veld, Stoops, de Boer, Duits, Houwer, Morrema, Alcolea, Illán-Gala, Fortea, Lleó, Boxer, Irwin, Lee, Shaw, McMillan, Wolk, Hoozemans, van der Flier, van der Ende, Seelaar, Verberk, Gan, Pijnenburg, Teunissen: An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Degeneration. Invited Talk: Restoring Neural Resilience in ALS and Alzheimer’s Disease 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.176 Cousins, Boyle, Morse, Verma, Brown, O’Brien, Serper, Dehghani, Penn Medicine BioBank, McMillan, Lee, Shaw, & Wolk: Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s disease. Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
187 Simrén, Rönnholm, Weiner, Pola, Benedet, Shaw, Wolk, Weintraub, Lee, McMillan, Blennow, Irwin, Zetterberg*, Gobom*, & Cousins*: Cerebrospinal fluid proteomic profiling in frontotemporal lobar degeneration, Alzheimer’s disease and Lewy body disease. Invited Talk: Biomarker Signatures in Preclinical AD and Neurodegenerative Diseases 51 Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.
1d4 Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.: Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch. JAMA Neurol 83: 126-136, Feb 2026.
168 Cousins KAQ, Boyle R, Morse C, Verma A, Brown CA, O'Brien KS, Serper M, Dehghani N; Penn Medicine BioBank; McMillan CT, Lee EB, Shaw LM, Wolk DA.: Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease. Ann Neurol Dec 2025.
84 Kwiecinski, Dratch, Andrews, Dengel, Kamel, Legaspi, McMillan, Massimo, Cousins, & Irwin d4 : Evaluating the Impact of Predictive Genetic Counseling in Frontotemporal Dementia: A Pilot Analysis. National Society of Genetic Counselors (NSGC) 44th Annual Conference Nov 2025.
7b Ohm, Capp, Sabitini, Cousins, Phillips, Rascovsky, Wolk, Lee, McMillan, & Irwin 2 a1 : Selectively vulnerable myeloarchitecture in behavioral variant frontotemporal dementia. Society for Neuroscience (SfN) Nov 2025.
16f Luna, Cousins, Emrani, Luk, Lee, Lee, Weintraub, Xie, Chen-Plotkin, Bennett, & Irwin: Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner. International Congress of Parkinson’s Disease and Movement Disorders Oct 2025.
19b Brown CA, Cousins KAQ, Korecka M, McGrew E, Chen-Plotkin A, Detre JA, McMillan CT, Lee EB, Das SR, Mechanic-Hamilton D, Yushkevich PA, Nasrallah IM, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative; Wolk DA.: Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease using PET and Plasma Biomarkers. medRxiv Sep 2025.
1b1 Boyle R, Dehghani N, Emrani S, Wadhwani AR, Matyi M, Cousins KAQ, Rhodes E, Nelson B, Stites SD, Xie SX, Dratch L, Van Deerlin VM, Snyder A, Irwin DJ, McMillan CT, Massimo L.: Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degeneration. Alzheimers Dement Behav Socioecon Aging Sept 2025.
2c
4d
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10